AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

MEDICAL DEVELOPMENTS INTERNA

0.425

-0.025-5.56%

Volume:183.75K

Turnover:79.31K

Market Cap:47.88M

PE:-1.38

High:0.450

Open:0.450

Low:0.420

Close:0.450

Loading ...

Overview Company News Filings

ASX Value Picks Featuring Judo Capital Holdings And Two Other Stocks With Estimated Low Valuations

Simply Wall St.

Initia Co-founder Disclosure: Binance Labs is Initia's first and largest investor

ASX April 2025: Highlighting Three Stocks That May Be Trading Below Estimated Value

Simply Wall St.

3 ASX Stocks Estimated To Be Up To 49.8% Below Intrinsic Value

Simply Wall St.

UXLINK's Q1 2025 Growth and Profit Soar, Paving the Way for Industry Growth

Medical Developments International Limited (ASX:MVP) Shares Could Be 38% Below Their Intrinsic Value Estimate

Simply Wall St.

Take Care Before Jumping Onto Medical Developments International Limited (ASX:MVP) Even Though It's 27% Cheaper

Simply Wall St.

Medical Developments International Limited Just Reported A Surprise Profit And Analysts Updated Their Estimates

Simply Wall St.

Shareholders in Medical Developments International (ASX:MVP) have lost 90%, as stock drops 13% this past week

Simply Wall St.

Benign Growth For Medical Developments International Limited (ASX:MVP) Underpins Its Share Price

Simply Wall St.

Medical Developments International Insiders Placed Bullish Bets Worth AU$3.36m

Simply Wall St.

Optiscan doubles revenue, boosts profit for Sep qtr

The Sydney Morning Herald

BRIEF-Medical Developments International Sees FY25 Underlying EBIT To Be Improved On FY24

Medical Developments International Sees FY25 Underlying EBIT to Be Strongly Improved on FY24

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/MVP.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MVP.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MVP.AU\",,,,,undefined,":{"symbol":"MVP.AU","market":"AU","secType":"STK","nameCN":"MEDICAL DEVELOPMENTS INTERNA","latestPrice":0.425,"timestamp":1745302320000,"preClose":0.45,"halted":0,"volume":183746,"delay":0,"nameEN":"MEDICAL DEVELOPMENTS INTERNA","floatShares":81690477,"shares":112658324,"eps":-0.307192,"marketStatus":"Closed","change":-0.025,"latestTime":"04-22 16:12:00 AEST","open":0.45,"high":0.45,"low":0.42,"amount":79309,"amplitude":0.066667,"askPrice":0.43,"askSize":5951,"bidPrice":0.425,"bidSize":1159,"shortable":3,"etf":0,"ttmEps":-0.307192,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1745366400000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.45,"openAndCloseTimeList":[[1745280000000,1745301600000]],"volumeRatio":2.04111,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MVP.AU\",,,,,undefined,":{"symbol":"MVP.AU","floatShares":81690477,"roa":"-1.23%","roe":"-45.40%","lyrEps":-0.474965,"volumeRatio":2.04111,"shares":112658324,"dividePrice":0,"high":0.45,"amplitude":0.066667,"preClose":0.45,"low":0.42,"week52Low":0.375,"pbRate":"0.87","psRate":"1.26","week52High":0.94,"institutionHeld":0,"latestPrice":0.425,"committee":-0.67398,"eps":-0.307192,"divideRate":0,"volume":183746,"delay":0,"ttmEps":-0.307192,"open":0.45,"prevYearClose":0.405,"prevWeekClose":0.45,"prevMonthClose":0.555,"prevQuarterClose":0.555,"fiveDayClose":0.5,"twentyDayClose":0.62,"sixtyDayClose":0.4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MVP.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2528778081","title":"ASX Value Picks Featuring Judo Capital Holdings And Two Other Stocks With Estimated Low Valuations","url":"https://stock-news.laohu8.com/highlight/detail?id=2528778081","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528778081?lang=en_us&edition=fundamental","pubTime":"2025-04-18 03:34","pubTimestamp":1744918483,"startTime":"0","endTime":"0","summary":"As the Australian market navigates a unique path, diverging from Wall Street to close above the 7,800 points level, investors are keenly observing sector performances with energy leading gains. In this environment of mixed sector outcomes and individual stock volatility, identifying undervalued stocks like Judo Capital Holdings can offer potential opportunities for those looking to capitalize on estimated low valuations.Top 10 Undervalued Stocks Based On Cash Flows In Australia. Judo Capital Holdings is trading at A$1.73, below its estimated fair value of A$2.22, indicating it may be undervalued based on cash flows. Despite recent earnings showing a slight decline in net income to A$40.9 million for the half-year ending December 2024, Judo's earnings are forecast to grow significantly at 29.6% annually, outpacing the Australian market average of 11.7%. However, insider selling over the past quarter could be a concern for potential investors.Overview: Superloop Limited, along with its s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/asx-value-picks-featuring-judo-193443122.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["JDO.AU","ACF.AU","BK7055","XKO.AU","EOS.AU","3DA.AU","IDX.AU","BK7096","BK7508","XJO.AU","SLC.AU","BK7115","BK7015","PNR.AU","VAU.AU","BK7135","BK7088","BK7031","XAO.AU","GNP.AU","MVP.AU","JDOPA.AU","BK7104","NXL.AU","BK7016","BK7124"],"gpt_icon":0},{"id":"2528740616","title":"Initia Co-founder Disclosure: Binance Labs is Initia's first and largest investor","url":"https://stock-news.laohu8.com/highlight/detail?id=2528740616","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528740616?lang=en_us&edition=fundamental","pubTime":"2025-04-17 23:21","pubTimestamp":1744903260,"startTime":"0","endTime":"0","summary":"BlockBeats News, April 17th, Zon, co-founder of the Layer 1 Rollup network Initia, stated in a social media post, \"As early as the beginning of 2023, Binance Labs  became our first investor and the largest investor to date.\"At that time, Initia was only relying on a vision and a minimal viable product  to survive, and fortunately, Binance Labs saw it. I prefer to believe that what they saw more importantly was the strength of the team we were building.\"Today's report, Initia  has been launched on Binance Launchpool.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/290179","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["MVP","MVP.AU","BK7508","BK7096"],"gpt_icon":0},{"id":"2527422174","title":"ASX April 2025: Highlighting Three Stocks That May Be Trading Below Estimated Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2527422174","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527422174?lang=en_us&edition=fundamental","pubTime":"2025-04-16 03:34","pubTimestamp":1744745665,"startTime":"0","endTime":"0","summary":"The Australian market has experienced a relatively stable day, with the ASX200 closing at 7,760 points and sectors such as Health Care showing positive movement while others like Staples lagged. In this context of fluctuating sector performances and strategic shifts among companies, identifying stocks that may be trading below their estimated value can present potential opportunities for investors looking to capitalize on market inefficiencies.Top 10 Undervalued Stocks Based On Cash Flows In Australia. Here we highlight a subset of our preferred stocks from the screener.Overview: Corporate Travel Management Limited is a travel management solutions company that oversees the procurement and delivery of travel services across Australia and New Zealand, North America, Asia, and Europe, with a market cap of A$1.77 billion.Unlock comprehensive insights into our analysis of Corporate Travel Management stock in this financial health report.Overview: Nick Scali Limited, with a market cap of A$1","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/asx-april-2025-highlighting-three-193425216.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7096","GSS.AU","NXL.AU","BK7031","BK7117","GNP.AU","XKO.AU","XJO.AU","3DA.AU","BK7115","XAO.AU","SHV.AU","BK7048","MVP.AU","BK7016","ACF.AU","BK7124","EOS.AU","BK7107","BK7088","BK7505","PNR.AU","BK7070","BK7508","BK7501","BK7055","BK7104","PNRDA.AU","NCK.AU","IDX.AU","CTD.AU"],"gpt_icon":0},{"id":"2526334884","title":"3 ASX Stocks Estimated To Be Up To 49.8% Below Intrinsic Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2526334884","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526334884?lang=en_us&edition=fundamental","pubTime":"2025-04-10 03:34","pubTimestamp":1744227269,"startTime":"0","endTime":"0","summary":"The Australian market has recently experienced significant volatility, with tariff-driven panic selling affecting most sectors and energy stocks being particularly hard hit due to a drop in Brent Crude prices. Amidst these challenging conditions, identifying undervalued stocks can present opportunities for investors looking to capitalize on price discrepancies relative to intrinsic value.Top 10 Undervalued Stocks Based On Cash Flows In Australia. Deep Yellow is trading at A$0.79, significantly below its estimated fair value of A$1.56, suggesting it may be undervalued based on cash flows. The company reported a substantial revenue increase to A$6.29 million for the half-year ended December 2024, though it remains unprofitable with a net loss of A$2.47 million. Expected revenue growth of 137.6% annually outpaces the market average, supporting its potential as an undervalued opportunity despite current losses.Lynas Rare Earths is trading at A$7.69, slightly below its estimated fair value ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-asx-stocks-estimated-49-193429442.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["NCK.AU","SHV.AU","BK7124","BK7095","BK7503","BK7104","XAO.AU","BK7507","BK7508","LYC.AU","BK7083","MP1.AU","BK7107","IDX.AU","BK7043","BK7117","BK7096","POL.AU","XJO.AU","PNR.AU","BK7505","JHX.AU","BK7044","BK7128","MVP.AU","XKO.AU","DSK.AU","DYL.AU","LBL.AU","BK7088"],"gpt_icon":0},{"id":"2526220382","title":"UXLINK's Q1 2025 Growth and Profit Soar, Paving the Way for Industry Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2526220382","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526220382?lang=en_us&edition=fundamental","pubTime":"2025-04-09 14:38","pubTimestamp":1744180680,"startTime":"0","endTime":"0","summary":"BlockBeats News, April 9th: In the challenging market environment of the first quarter of 2025, UXLINK not only achieved strong growth but also recorded solid profits.The UXLINK ecosystem has always been centered on \"growth,\" committed to providing users with a seamless experience, and enabling healthy growth for projects and builders through top-notch infrastructure, tools, and traffic support. With successful Product-Market-Fit  validation, as long as the industry maintains its upward momentum, the demand for growth will never diminish. The UXLINK ecosystem's Minimum-Viable-Product  has also been fully validated, achieving a net profit of over tens of millions of dollars, entering a positive cycle.The head of the UXLINK ecosystem stated: We expect the full-year net profit for 2025 to reach $20-30 million. Looking ahead, with the introduction of the PAYFI system, next-generation AI tools, and more innovative projects, UXLINK's profits will experience explosive growth!We will continue ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/288963","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["MVP.AU","BK7508","PMF","BK7096","MVP"],"gpt_icon":0},{"id":"2522833558","title":"Medical Developments International Limited (ASX:MVP) Shares Could Be 38% Below Their Intrinsic Value Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2522833558","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522833558?lang=en_us&edition=fundamental","pubTime":"2025-03-26 04:18","pubTimestamp":1742933930,"startTime":"0","endTime":"0","summary":"The projected fair value for Medical Developments International is AU$0.89 based on 2 Stage Free Cash Flow to Equity. Medical Developments International is estimated to be 38% undervalued based on current share price of AU$0.56. Medical Developments International's peers seem to be trading at a higher discount to fair value based onthe industry average of 42%. How far off is Medical Developments International Limited  from its intrinsic value?Using the most recent financial data, we'll take a look at whether the stock is fairly priced by taking the expected future cash flows and discounting them to today's value. We will use the Discounted Cash Flow  model on this occasion. Don't get put off by the jargon, the math behind it is actually quite straightforward.Remember though, that there are many ways to estimate a company's value, and a DCF is just one method. For those who are keen learners of equity analysis, the Simply Wall St analysis model here may be something of interest to you.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/medical-developments-international-limited-asx-201850382.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["MVP","MVP.AU","BK7508","BK4211","TV","FCF","BK4100","DCF","BK7096"],"gpt_icon":0},{"id":"2520558848","title":"Take Care Before Jumping Onto Medical Developments International Limited (ASX:MVP) Even Though It's 27% Cheaper","url":"https://stock-news.laohu8.com/highlight/detail?id=2520558848","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520558848?lang=en_us&edition=fundamental","pubTime":"2025-03-17 06:14","pubTimestamp":1742163270,"startTime":"0","endTime":"0","summary":"The Medical Developments International Limited ( ASX:MVP ) share price has softened a substantial 27% over the previous...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-mvp/medical-developments-international-shares/news/take-care-before-jumping-onto-medical-developments-internati","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7096","MVP","BK7508","MVP.AU"],"gpt_icon":0},{"id":"2513006342","title":"Medical Developments International Limited Just Reported A Surprise Profit And Analysts Updated Their Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2513006342","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513006342?lang=en_us&edition=fundamental","pubTime":"2025-02-23 07:12","pubTimestamp":1740265962,"startTime":"0","endTime":"0","summary":"It's been a sad week for Medical Developments International Limited , who've watched their investment drop 13% to AU$0.80 in the week since the company reported its interim result. Although revenues of AU$20m were in line with analyst expectations, Medical Developments International surprised on the earnings front, with an unexpected  profit of AU$0.0027 per share a nice improvement on the losses that the analystforecast. Following the result, the analyst has updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. With this in mind, we've gathered the latest statutory forecasts to see what the analyst is expecting for next year.Check out our latest analysis for Medical Developments International. Following on from that line of thought, we think that the long-term prospects of the business are much more relevant","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/medical-developments-international-limited-just-231242630.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7508","MVP.AU","BK7096"],"gpt_icon":1},{"id":"2513481052","title":"Shareholders in Medical Developments International (ASX:MVP) have lost 90%, as stock drops 13% this past week","url":"https://stock-news.laohu8.com/highlight/detail?id=2513481052","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513481052?lang=en_us&edition=fundamental","pubTime":"2025-02-22 05:27","pubTimestamp":1740173244,"startTime":"0","endTime":"0","summary":"This month, we saw the Medical Developments International Limited  up an impressive 96%. But spare a thought for the long term holders, who have held the stock as it bled value over the last five years. Five years have seen the share price descend precipitously, down a full 90%. It's true that the recent bounce could signal the company is turning over a new leaf, but we are not so sure. The important question is if the business itself justifies a higher share price in the long term. We really hope anyone holding through that price crash has a diversified portfolio. Even when you lose money, you don't have to lose the lesson.With the stock having lost 13% in the past week, it's worth taking a look at business performance and seeing if there's any red flags.View our latest analysis for Medical Developments International. Medical Developments International is not the only stock insiders are buying. So take a peek","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/shareholders-medical-developments-international-asx-212724472.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7096","BK7508","MVP.AU","MVP"],"gpt_icon":0},{"id":"2507669600","title":"Benign Growth For Medical Developments International Limited (ASX:MVP) Underpins Its Share Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2507669600","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507669600?lang=en_us&edition=fundamental","pubTime":"2025-01-31 04:28","pubTimestamp":1738268916,"startTime":"0","endTime":"0","summary":"With a price-to-sales (or \"P/S\") ratio of 1.5x Medical Developments International Limited ( ASX:MVP ) may be sending...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-mvp/medical-developments-international-shares/news/benign-growth-for-medical-developments-international-limited","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MVP","BK7096","BK7508","MVP.AU"],"gpt_icon":0},{"id":"2484900052","title":"Medical Developments International Insiders Placed Bullish Bets Worth AU$3.36m","url":"https://stock-news.laohu8.com/highlight/detail?id=2484900052","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484900052?lang=en_us&edition=fundamental","pubTime":"2024-11-20 06:41","pubTimestamp":1732056095,"startTime":"0","endTime":"0","summary":"Multiple insiders secured a larger position in Medical Developments International Limited  shares over the last 12 months. This is reassuring as this suggests that insiders have increased optimism about the company's prospects.While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we do think it is perfectly logical to keep tabs on what insiders are doing.View our latest analysis for Medical Developments International. Medical Developments International Insider Transactions Over The Last Year. Medical Developments International insiders may have bought shares in the last year, but they didn't sell any. Their average price was about AU$0.94. These transactions suggest that insiders have considered the current price attractive. You can see a visual depiction of insider transactions  over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/H9sVDVM9mi9ws1HvXhxW7w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/H9sVDVM9mi9ws1HvXhxW7w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/medical-developments-international-insiders-placed-224135700.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["MVP.AU","BK7508","BK7096"],"gpt_icon":0},{"id":"2479372501","title":"Optiscan doubles revenue, boosts profit for Sep qtr","url":"https://stock-news.laohu8.com/highlight/detail?id=2479372501","media":"The Sydney Morning Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479372501?lang=en_us&edition=fundamental","pubTime":"2024-10-31 15:29","pubTimestamp":1730359740,"startTime":"0","endTime":"0","summary":"Innovative medical device company Optiscan Imaging doubled revenues and tabled its first significant quarterly cash profit from sales this year after a news-filled September quarter.Solid buying suppo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.smh.com.au/business/companies/optiscan-doubles-revenue-boosts-profit-for-sep-qtr-20241031-p5kmzs.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"smh_stock","symbols":["MVP","BK7508","MVP.AU","BK7096"],"gpt_icon":0},{"id":"2477870477","title":"BRIEF-Medical Developments International Sees FY25 Underlying EBIT To Be Improved On FY24","url":"https://stock-news.laohu8.com/highlight/detail?id=2477870477","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477870477?lang=en_us&edition=fundamental","pubTime":"2024-10-22 14:58","pubTimestamp":1729580293,"startTime":"0","endTime":"0","summary":"Oct 22 (Reuters) - Medical Developments International Ltd   :   * SEES  FY25 UNDERLYING EBIT TO BE STRONGLY IMPROVED ON FY24Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MVP.AU","BK7508","BK7096"],"gpt_icon":0},{"id":"2477582699","title":"Medical Developments International Sees  FY25 Underlying EBIT to Be Strongly Improved on FY24","url":"https://stock-news.laohu8.com/highlight/detail?id=2477582699","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477582699?lang=en_us&edition=fundamental","pubTime":"2024-10-22 10:04","pubTimestamp":1729562665,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241022:nFWN3LY001:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","BK7508","MVP.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":14,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MVP.AU\",params:#limit:5,,,undefined,":[{"date":"2025-02-20","symbol":"MVP.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740006000000,"name":null,"time":"","dateTimestamp":1739970000000,"actualEps":null},{"date":"2024-08-26","symbol":"MVP.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724630400000,"name":null,"time":"","dateTimestamp":1724594400000,"actualEps":null},{"date":"2024-02-29","symbol":"MVP.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1709161200000,"name":null,"time":"","dateTimestamp":1709125200000,"actualEps":null},{"date":"2023-08-31","symbol":"MVP.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1693440000000,"name":null,"time":"","dateTimestamp":1693404000000,"actualEps":null},{"date":"2023-02-24","symbol":"MVP.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1677193200000,"name":null,"time":"","dateTimestamp":1677157200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MVP.AU\",market:\"AU\",,,undefined,":[]}}